Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$0.2 - $0.5 $15,339 - $38,348
-76,696 Reduced 99.88%
93 $0
Q1 2022

May 11, 2022

BUY
$0.41 - $0.63 $5,088 - $7,818
12,411 Added 19.28%
76,789 $42,000
Q4 2021

Feb 10, 2022

SELL
$0.57 - $1.29 $18,767 - $42,474
-32,926 Reduced 33.84%
64,378 $37,000
Q3 2021

Nov 12, 2021

BUY
$1.11 - $1.7 $108,007 - $165,416
97,304 New
97,304 $119,000

About TREVENA INC


  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $273M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.